미국 - 영어 - NLM (National Library of Medicine)

aurobindo pharma limited - telmisartan (unii: u5syw473rq) (telmisartan - unii:u5syw473rq), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - telmisartan 40 mg - telmisartan and hydrochlorothiazide tablets  are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the classes to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with telmisartan and hydrochlorothiazide tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national commit

미국 - 영어 - NLM (National Library of Medicine)

torrent pharmaceuticals limited - telmisartan (unii: u5syw473rq) (telmisartan - unii:u5syw473rq), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - telmisartan 40 mg - telmisartan and hydrochlorothiazide tablets, are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the classes to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with telmisartan and hydrochlorothiazide tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national commit

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

chemo iberica s.a. - hydrochlorothiazide 12,5 mg; telmisartan 40 mg - tablet - 40 mg - 12,5 mg - telmisartan 40 mg; hydrochlorothiazide 12.5 mg - telmisartan and diuretics

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratorios liconsa s.a. - hydrochlorothiazide 12,5 mg; telmisartan 80 mg - tablet - 80 mg - 12;5 mg - telmisartan 80 mg; hydrochlorothiazide 12.5 mg - telmisartan and diuretics

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - telmisartan -

미국 - 영어 - NLM (National Library of Medicine)

zydus lifesciences limited - telmisartan (unii: u5syw473rq) (telmisartan - unii:u5syw473rq), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - telmisartan 40 mg - telmisartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the classes to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with telmisartan and hydrochlorothiazide tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committ

캐나다 - 영어 - Health Canada

sanis health inc - hydrochlorothiazide; telmisartan - tablet - 12.5mg; 80mg - hydrochlorothiazide 12.5mg; telmisartan 80mg - angiotensin ii receptor antagonists

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - telmisartan, hydrochlorothiazide - tablets - 80/25 milligram - angiotensin ii antagonists and diuretics

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - telmisartan, hydrochlorothiazide - tablets - 40/12.5 milligram - angiotensin ii antagonists and diuretics

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - telmisartan, hydrochlorothiazide - tablets - 80/12.5 milligram - angiotensin ii antagonists and diuretics